维普期刊资源整合服务平台（V6.5）

287篇 您的检索式：作者名="STADLER T"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	Evolution of spliceo- somal snRNA genes in metazoan animals显示文摘	Marz M Kirsten T Stadler PF	2008	J Mol Evol2008，67，6：	1
2	Sorafenib in advanced clear-cell renal -cell carcinoma 显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl JMed2007，356，2：	1
3	Sorafenib in advanced clear-cell renal-cell carcinoma显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，：	1
4	Optimal design of ex- periments for estimating parameters of a vehiele dy- namics simulation model显示文摘	Butz T Simeon B Stadler M	2010	Journal of Computa- tional and Nonlinear Dynamics2010，5，03：	1
5	Oviposition of carrot fly (Psila rosae) in response to foliage and leaf surface extracts of host plants显示文摘	Degen T Stadler E	1998	Chemoecolo- gy1998，8，1：	1
6	Sorafenib in advanced clearcell renal cell carcinoma显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，2：	1
7	Phase Ⅱ placebocontrolled random ized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma显示文摘	RatainMJ Eisen T Stadler WM	2006	J Clin Oncol2006，24，：	1
8	Sorafenib in advanced clear-cell renal-cell carcinoma显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，2：	1
9	Sorafenib fortreatment of renal cell carcinoma: Final efficacy and safety results of the phase m treatment approaches in renal cancer global evaluation triaI显示文摘	Escudier B Eisen T Stadler WM	2009	) Clin Oneol2009，27，20：	1
10	Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial显示文摘	Escudier B Eisen T Stadler WM	2009	J Clin Oncol2009，27，20：	1
11	Increased p16 levels correlate with pRb alterations in human urothelial cells显示文摘	Yeager T stadler W Belair C	1995	Cancer Res1995，55，：	1
12	RAPD identification of microsatellite in Dphnia显示文摘	Ender A Schwenk K Stadler T	1996	Mol Ecol1996，5，3：	1
13	Sorafenib in ad- vanced clear-cell renal-cell carcinoma 显示文摘	Escudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，2：	1
14	Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma 显示文摘	Ratain M J Eisen T Stadler WM	2006	J Clin Oncol2006，24，16：	1
15	Final findings from a phase Ⅱ, placebo-controlled, randomized discontinuatoin trial (RDT) of Sorafenib (Bay 43 - 9006) in patients with advanced renal cell carcinoma (RCC)(abstract) 显示文摘	Ratain MJ Eisen T Stadler WM	2005	J Clin Oncol2005，23，16：	1
16	Phase Ⅱ placebo-controlled randomized discontinuation trial (RDT) of sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC)显示文摘	Ratain MJ Eisen T Stadler WM	2006	Clin Oncol2006，24，16：	1
17	The Journal of Gene Medicine 显示文摘	Stadler J Lemmens R Nyhammar T	2004	6(S1): $54-$662004，6，1：	1
18	Increased p16 levels correlate with pRb alterations in buman urothelial cells显示文摘	Yeager T Stadler W Belair C	1995	Cancer Res1995，55，：	1
19	Developments in and practical guidelines for tip-enhanced Raman spectroscopy显示文摘	Stadler J Schmid T Zenobi R	2012	Nanoscale2012，4，6：	1
20	Phase Ⅱ placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma 显示文摘	Ratain M J Eisen T Stadler WM	2006	J Clin Oncol2006，24，16：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示